AIM-listed hospital disinfectant maker Tristel (TSTL) issued a positive H1 trading update and confirmed its FY outlook. It also announced CEO Matt Sassone would take up a post with a large US multinational from July 2026. Share price: 410p (+2.4%) PE: 24.3x Market cap: £195m Yield: 3.8% MARGIN EXPANSION Focusing on the H1 performance, revenue … Continue reading Tristel confirms FY outlook